Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass
- 1 June 1991
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 101 (6) , 958-967
- https://doi.org/10.1016/s0022-5223(19)36611-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Adenosine Spares Platelets During Cardiopulmonary Bypass in Man Without Causing Systemic VasodilatationScandinavian Journal of Thoracic and Cardiovascular Surgery, 1985
- Anaphylactic reaction to aprotinin despite negative ocular sensitivity tests.BMJ, 1984
- Disadvantages of Prostacyclin Infusion During Cardiopulmonary Bypass: A Double-Blind Study of 50 Patients Having Coronary RevascularizationThe Annals of Thoracic Surgery, 1984
- Hochdosierte Aprotinin (Trasylol)-Therapie —unschädlich für die Niere?Langenbecks Archives Of Surgery, 1983
- NATURAL PROTEINASE INHIBITORS IN EXTRACORPOREAL CIRCULATIONAnnals of the New York Academy of Sciences, 1968